Wound Care Biologic Market Size 2025-2029
The wound care biologic market size is forecast to increase by USD 701.3 million, at a CAGR of 5.5% between 2024 and 2029.
The expanding chronic wound care market is fundamentally shaped by the rising incidence of chronic diseases and an aging global population. These demographic shifts result in a greater occurrence of complex wounds where the body's natural tissue regeneration capabilities are impaired. This creates a clinical necessity for advanced wound care solutions that actively support cellular migration and re-epithelialization. Bioengineered skin substitutes and other biologic therapies are engineered to address these specific biological deficits, offering interventions designed to stimulate and guide the healing process where traditional methods are insufficient, thus driving demand for more sophisticated wound therapy devices.The industry is advancing toward combination therapies and the bioactive wound dressing market, creating sophisticated products that address multiple barriers to healing simultaneously. These solutions often integrate biologic agents with advanced materials to manage the wound microenvironment and support wound bed preparation following procedures common in the wound debridement market. However, the high cost of these advanced treatments and inconsistent reimbursement frameworks remain a primary challenge. This economic barrier limits broad access, forcing healthcare providers to balance the clinical benefits of superior healing outcomes against significant budgetary constraints, thereby affecting the adoption rate of these innovative biologic products.
What will be the Size of the Wound Care Biologic Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market's evolution is centered on the refinement of a decellularized dermal matrix and advanced extracellular matrix scaffolds, which form the basis of the biomaterial wound dressing market. Innovations in placental tissue biologics and amniotic fluid allograft technologies are enhancing tissue regeneration efficacy. These bioengineered skin substitutes are critical in advanced wound care, providing platforms that actively support angiogenesis stimulation and improve healing outcomes for complex wounds. The continuous development of these foundational technologies addresses the growing need for more effective and biologically active treatment solutions.The therapeutic focus is shifting toward leveraging cellular mechanisms to accelerate healing. Autologous cell harvesting techniques and the application of cellular therapies are pivotal in promoting cellular migration support. This approach requires meticulous wound bed preparation to optimize the environment for re-epithelialization and achieve a faster wound closure rate. The principles of moist wound healing are integrated into these advanced protocols, which are becoming central to the chronic wound care market and are supported by innovations in patch-based wound healing.Specialized product categories are being developed to address specific clinical challenges in the wound debridement market. The use of collagen-based scaffolds for tissue repair and advanced hydrofiber technology is becoming standard for managing difficult wounds. In parallel, enzymatic debridement agents are employed to prepare the wound for biologic application. These targeted solutions are essential for effective diabetic foot ulcer treatment and venous leg ulcer management, often used in conjunction with systems like surgical drains/wound drainage market products to manage exudate.
How is this Wound Care Biologic Industry segmented?
The wound care biologic industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Product
- Skin substitutes
- Cell based products
- Collagen based products
- Topical agents
- Others
- Application
- Ulcers
- Surgical and traumatic wounds
- Burns
- Others
- End-user
- Hospitals and clinics
- ASCs
- Burn centers and wound clinics
- Others
- Geography
- North America
- Europe
- Germany
- UK
- France
- Russia
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
By Product Insights
The skin substitutes segment is estimated to witness significant growth during the forecast period.
The skin substitutes segment is a dynamic component of the wound care biologics landscape. These products are engineered to replicate the natural structure and function of skin, providing a cover for severe wounds like chronic ulcers. The category includes both cellular substitutes with living cells and acellular substitutes that offer a decellularized scaffold to promote tissue regeneration. Skin substitutes accounted for over 37% of the market in the previous year, highlighting their significant role in advanced wound management and treatment protocols.
Growth in this segment is driven by the increasing prevalence of complex chronic wounds that do not respond to traditional treatments. Innovation is geared toward creating products that are not only clinically effective but also more convenient for use in various care settings. The development of lyophilized, shelf-stable biologic skin substitutes, for example, demonstrates a focus on therapies that are easier to store and apply. This trend addresses a key market need for advanced solutions that enhance both efficacy and operational efficiency.
Request Free Sample
The Skin substitutes segment was valued at USD 751.80 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 37.0% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The North America region stands as the leader in the global wound care biologic market, driven by its sophisticated healthcare infrastructure and substantial healthcare spending. This environment facilitates the adoption of advanced wound care solutions for a significant patient population. The region represents the largest opportunity for market participants, accounting for nearly 37% of the global market. This dominance is a result of a mature market that is receptive to innovation and has established pathways for the use of high-value biologic therapies.
Key drivers within the North America market include the high prevalence of chronic conditions that lead to complex wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers. The region also benefits from a robust research and development ecosystem that fosters rapid innovation. Although complex, relatively well-established reimbursement frameworks are in place for many advanced wound care treatments, which supports patient access to these costly therapies and solidifies the region's market leadership and continued growth potential.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global wound care biologics market is witnessing significant expansion, driven by the increasing demand for solutions capable of effectively regulating the wound healing cascade. Innovations are focused on creating biologic matrices for chronic wounds and collagen-based scaffolds for tissue repair, which provide a structural foundation for cellular growth. The adoption of novel approaches such as decellularized fish skin graft technology and bioengineered tissue for skin regeneration is accelerating. Furthermore, cellular allografts for wound healing and the use of an extracellular matrix patch for ulcers are becoming standard protocols, demonstrating superior clinical outcomes alongside xenograft skin substitutes for trauma. These scaffolds for soft tissue augmentation represent a key area of development.In parallel, the market is defined by specialized advanced therapies for surgical wounds and trauma care, such as the use of an autologous cell suspension for burns and amniotic membrane for donor sites. Products like human placental tissue derived allografts and lyophilized amniotic fluid allograft are gaining traction. The application of topical growth factor wound therapy, including treatments utilizing recombinant platelet-derived growth factor, is pivotal. Effective treatment also requires managing wound bed bioburden, often achieved through enzymatic debriding agent application. From a market access perspective, a thorough cost analysis of biologic wound dressings is essential for providers, while accurate HCPCS coding for skin substitutes remains critical for reimbursement.
What are the key market drivers leading to the rise in the adoption of Wound Care Biologic Industry?
- The increasing prevalence of chronic diseases, combined with a globally aging population, serves as the fundamental driver for the market.
A fundamental driver for the market is the confluence of rising chronic disease rates and an aging population. Conditions like diabetes and obesity lead to hard-to-heal wounds, such as diabetic foot ulcers, where the natural healing cascade is compromised. Biologics, including skin substitutes and growth factors, are engineered to address these deficits and stimulate tissue regeneration. With nearly 17% of the world's population projected to be over 60 by 2030, the patient base requiring these advanced interventions for conditions like pressure ulcers is expanding. This creates a sustained and significant demand for therapies that can overcome the healing challenges inherent in these demographics.Continuous technological advancement and product innovation are critical engines for growth in the wound care biologic market. The field has evolved beyond passive dressings to include active therapies designed to intervene directly in the cellular processes of wound repair. Fueled by R&D investments, companies are developing novel biomaterials, cellular therapies, and placental-derived allografts. These bioengineered skin substitutes and tissues offer clinical advantages by shortening healing times and reducing complications. Clinical studies demonstrate that advanced therapies can improve healing outcomes by over 30% compared to standard care, highlighting the efficacy of this constant innovation cycle in driving market expansion.
What are the market trends shaping the Wound Care Biologic Industry?
- A significant upcoming trend is the rise of combination therapies and advanced bioactive dressings that provide a multi-faceted approach to wound care.
A dominant trend is the development of combination therapies and advanced products within the bioactive wound dressing market. This trend moves away from single-action items toward sophisticated solutions addressing multiple facets of the complex wound healing process, such as persistent inflammation and bacterial biofilm. Products are being designed to combine biologic agents like collagen and growth factors with antimicrobial components to create a more effective, multi-pronged approach. Clinical data shows that in some cases, over 74% of ulcers treated with advanced dressings heal completely, demonstrating the superior outcomes that drive adoption of these synergistic technologies in the advanced wound care space.A significant structural trend shaping the market is the shift in care delivery from inpatient hospital settings to outpatient facilities and home environments. This transition is driven by the need to reduce healthcare costs and cater to patient preferences for treatment in familiar surroundings. The development of user-friendly wound therapy devices, telehealth platforms, and portable diagnostic tools makes it feasible to manage complex wounds remotely. The transition to lower-cost settings is driven by the potential for significant savings, with some estimates suggesting a reduction in treatment costs by up to 25%. This decentralization fundamentally alters how biologic products are marketed, distributed, and used.
What challenges does the Wound Care Biologic Industry face during its growth?
- The high cost of wound care biologics and the presence of inconsistent reimbursement frameworks are key challenges affecting industry growth.
A primary impediment to the widespread adoption of wound care biologics is their high cost, which creates a significant barrier to access. The complex manufacturing processes for biologic skin substitutes and other regenerative therapies lead to a price point substantially higher than traditional dressings. This affordability issue is compounded by complex reimbursement landscapes. For instance, recent updates to payment policies included a 3.37% reduction in a key conversion factor, impacting physician payment. Such constant flux in payer rules and billing codes requires significant resources from manufacturers to navigate, acting as a substantial challenge to stable market growth.The regulatory pathways for wound care biologics are rigorous and time-consuming, presenting a substantial challenge. Products containing human cells, tissues, and cellular and tissue-based products are subject to intense scrutiny to ensure safety and efficacy. Products deemed more than minimally manipulated require a stringent approval process, including an investigational new drug application and a biologics license application. This regulatory interpretation is critical, as a change in classification can disrupt commercialization. Regulatory hurdles are particularly complex in key markets that represent over 35% of the global opportunity, requiring significant investment to navigate.
Exclusive Customer Landscape
The wound care biologic market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the wound care biologic market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, wound care biologic market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Amnio Technology LLC - The market provides a range of wound care biologics, including those derived from amniotic tissues and membranes, which offer biologic matrices to support healing and modulate inflammation. Key offerings feature biologic dressings, tissue-based products, and cell-assisted regenerative treatments designed to provide a scaffold for wound repair. These products, such as engineered tissue items and processed human tissue allografts, are intended to promote tissue integration, accelerate wound closure, and support overall regenerative care. The portfolio also includes biologically active dressings and matrices that facilitate moist wound healing and are integrated into comprehensive wound management solutions.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Amnio Technology LLC
- Aroa Biosurgery Ltd.
- Avita Medical Inc.
- B.Braun SE
- Celularity Inc.
- Coloplast AS
- ConvaTec Group Plc
- Derma Sciences Inc.
- Integra LifeSciences Corp.
- Kerecis Ltd.
- Marine Polymer Technologies Inc.
- Medline Industries LP
- MiMedx Group Inc.
- Molnlycke Health Care AB
- Organogenesis Holdings Inc.
- Skye Biologics Holdings LLC
- Smith and Nephew plc
- Stryker Corp.
- Vericel Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Wound Care Biologic Market
In May 2024, Convatec Group Plc announced positive results from a multinational randomized controlled trial for its AQUACEL Ag+ Extra dressing, which found that venous leg ulcers treated with the product were significantly more likely to heal completely compared to standard care.In May 2024, Organogenesis Holdings Inc. presented new clinical and scientific data on its advanced wound care product portfolio at the Symposium on Advanced Wound Care (SAWC) Spring meeting.In May 2024, Aroa Biosurgery Ltd. announced record revenue for the fourth quarter and the full fiscal year 2024, driven by strong growth in its portfolio of soft-tissue regeneration products.In April 2024, Smith and Nephew plc launched its RENASYS EDGE Negative Pressure Wound Therapy System in the US, a device designed to be user-friendly for patients receiving wound care at home.In April 2024, MiMedx Group, Inc. announced its financial results for the first quarter of 2024, reporting an 18% growth in net sales, reflecting robust demand for its placental biologic products.
Research Analyst Overview
The global wound care biologic market is characterized by the continuous evolution of cellular and tissue-based products, with the market demonstrating an expansion in its product portfolio and a notable industry growth expectation of 7% in the coming year. Innovations include advanced extracellular matrix scaffolds, decellularized dermal matrix, and bioengineered skin substitutes, alongside amniotic fluid allograft and placental tissue biologics. These technologies, often integrated with approaches like hydrofiber technology, are pivotal for wound bed preparation and effective wound microenvironment management. Their primary mechanisms focus on angiogenesis stimulation and tissue regeneration to facilitate moist wound healing, addressing complex conditions such as diabetic foot ulcer treatment, venous leg ulcer management, and pressure injury care through the use of recombinant human growth factors.Procedural advancements and regulatory pathways define the operational dynamics of the market, with practices like enzymatic debridement and autologous cell harvesting becoming more refined. The pipeline for novel therapies, including rho-kinase inhibitors, aims to enhance re-epithelialization and cellular migration support while managing scaffold biodegradation. Clinical success is measured by improvements in wound closure rate and healing time reduction, with a focus on tissue regeneration efficacy and the prevention of wound dehiscence. For market access, a comprehensive cost-effectiveness analysis, guided by the healthcare common procedure coding system (HCPCS), is essential. Navigating the investigational new drug application (IND), biologics license application (BLA), and 510K clearance processes remains critical for applications in complex soft tissue reconstruction and surgical site infection prevention, considering factors like bioactive dressing interaction and collagen synthesis promotion.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Wound Care Biologic Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
313
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 5.5%
|
|
Market growth 2024-2029
|
USD 701.3 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
5.2%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Russia, Italy, The Netherlands, Spain, China, Japan, India, South Korea, Singapore, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Australia, South Africa, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Wound Care Biologic Market Research and Growth Report?
- CAGR of the Wound Care Biologic industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the wound care biologic market growth of industry companies
We can help! Our analysts can customize this wound care biologic market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Wound Care Biologic Market 2019 - 2023
- Historic Market Size - Data Table on Global Wound Care Biologic Market 2019 - 2023 ($ billion)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 Impact of AI in the global wound care biologic market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Skin substitutes - Market size and forecast 2024-2029
- Chart on Skin substitutes - Market size and forecast 2024-2029 ($ billion)
- Data Table on Skin substitutes - Market size and forecast 2024-2029 ($ billion)
- Chart on Skin substitutes - Year-over-year growth 2024-2029 (%)
- Data Table on Skin substitutes - Year-over-year growth 2024-2029 (%)
- 8.4 Cell based products - Market size and forecast 2024-2029
- Chart on Cell based products - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cell based products - Market size and forecast 2024-2029 ($ billion)
- Chart on Cell based products - Year-over-year growth 2024-2029 (%)
- Data Table on Cell based products - Year-over-year growth 2024-2029 (%)
- 8.5 Collagen based products - Market size and forecast 2024-2029
- Chart on Collagen based products - Market size and forecast 2024-2029 ($ billion)
- Data Table on Collagen based products - Market size and forecast 2024-2029 ($ billion)
- Chart on Collagen based products - Year-over-year growth 2024-2029 (%)
- Data Table on Collagen based products - Year-over-year growth 2024-2029 (%)
- 8.6 Topical agents - Market size and forecast 2024-2029
- Chart on Topical agents - Market size and forecast 2024-2029 ($ billion)
- Data Table on Topical agents - Market size and forecast 2024-2029 ($ billion)
- Chart on Topical agents - Year-over-year growth 2024-2029 (%)
- Data Table on Topical agents - Year-over-year growth 2024-2029 (%)
- 8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Application
- 9 Market Segmentation by Application
- 9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 9.3 Ulcers - Market size and forecast 2024-2029
- Chart on Ulcers - Market size and forecast 2024-2029 ($ billion)
- Data Table on Ulcers - Market size and forecast 2024-2029 ($ billion)
- Chart on Ulcers - Year-over-year growth 2024-2029 (%)
- Data Table on Ulcers - Year-over-year growth 2024-2029 (%)
- 9.4 Surgical and traumatic wounds - Market size and forecast 2024-2029
- Chart on Surgical and traumatic wounds - Market size and forecast 2024-2029 ($ billion)
- Data Table on Surgical and traumatic wounds - Market size and forecast 2024-2029 ($ billion)
- Chart on Surgical and traumatic wounds - Year-over-year growth 2024-2029 (%)
- Data Table on Surgical and traumatic wounds - Year-over-year growth 2024-2029 (%)
- 9.5 Burns - Market size and forecast 2024-2029
- Chart on Burns - Market size and forecast 2024-2029 ($ billion)
- Data Table on Burns - Market size and forecast 2024-2029 ($ billion)
- Chart on Burns - Year-over-year growth 2024-2029 (%)
- Data Table on Burns - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
10 Market Segmentation by End-user
- 10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 10.4 ASCs - Market size and forecast 2024-2029
- Chart on ASCs - Market size and forecast 2024-2029 ($ billion)
- Data Table on ASCs - Market size and forecast 2024-2029 ($ billion)
- Chart on ASCs - Year-over-year growth 2024-2029 (%)
- Data Table on ASCs - Year-over-year growth 2024-2029 (%)
- 10.5 Burn centers and wound clinics - Market size and forecast 2024-2029
- Chart on Burn centers and wound clinics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Burn centers and wound clinics - Market size and forecast 2024-2029 ($ billion)
- Chart on Burn centers and wound clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Burn centers and wound clinics - Year-over-year growth 2024-2029 (%)
- 10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 Russia - Market size and forecast 2024-2029
- Chart on Russia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- 12.4.5 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.4.6 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.4.7 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.2 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.5.5 Singapore - Market size and forecast 2024-2029
- Chart on Singapore - Market size and forecast 2024-2029 ($ billion)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ billion)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- 12.5.6 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.5.7 Thailand - Market size and forecast 2024-2029
- Chart on Thailand - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ billion)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.3 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.4 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.6.5 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.6 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of chronic diseases and aging population
- Technological advancements and product innovation
- Growing number of geriatric populations
- 13.2 Market challenges
- High cost and inconsistent reimbursement frameworks
- Stringent and evolving regulatory hurdles in market
- Competition from traditional wound care and deficient clinician awareness
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Rise of combination therapies and bioactive dressings
- Shift in point of care to outpatient and home settings
- Increased consolidation through mergers and acquisitions
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Amnio Technology LLC
- Amnio Technology LLC - Overview
- Amnio Technology LLC - Product / Service
- Amnio Technology LLC - Key offerings
- SWOT
- 15.5 Aroa Biosurgery Ltd.
- Aroa Biosurgery Ltd. - Overview
- Aroa Biosurgery Ltd. - Product / Service
- Aroa Biosurgery Ltd. - Key offerings
- SWOT
- 15.6 Avita Medical Inc.
- Avita Medical Inc. - Overview
- Avita Medical Inc. - Product / Service
- Avita Medical Inc. - Key offerings
- SWOT
- 15.7 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
- 15.8 Coloplast AS
- Coloplast AS - Overview
- Coloplast AS - Business segments
- Coloplast AS - Key news
- Coloplast AS - Key offerings
- Coloplast AS - Segment focus
- SWOT
- 15.9 Integra LifeSciences Corp.
- Integra LifeSciences Corp. - Overview
- Integra LifeSciences Corp. - Business segments
- Integra LifeSciences Corp. - Key news
- Integra LifeSciences Corp. - Key offerings
- Integra LifeSciences Corp. - Segment focus
- SWOT
- 15.10 Kerecis Ltd.
- Kerecis Ltd. - Overview
- Kerecis Ltd. - Product / Service
- Kerecis Ltd. - Key offerings
- SWOT
- 15.11 Marine Polymer Technologies Inc.
- Marine Polymer Technologies Inc. - Overview
- Marine Polymer Technologies Inc. - Product / Service
- Marine Polymer Technologies Inc. - Key offerings
- SWOT
- 15.12 Medline Industries LP
- Medline Industries LP - Overview
- Medline Industries LP - Product / Service
- Medline Industries LP - Key offerings
- SWOT
- 15.13 MiMedx Group Inc.
- MiMedx Group Inc. - Overview
- MiMedx Group Inc. - Business segments
- MiMedx Group Inc. - Key offerings
- MiMedx Group Inc. - Segment focus
- SWOT
- 15.14 Molnlycke Health Care AB
- Molnlycke Health Care AB - Overview
- Molnlycke Health Care AB - Product / Service
- Molnlycke Health Care AB - Key offerings
- SWOT
- 15.15 Organogenesis Holdings Inc.
- Organogenesis Holdings Inc. - Overview
- Organogenesis Holdings Inc. - Product / Service
- Organogenesis Holdings Inc. - Key offerings
- SWOT
- 15.16 Smith and Nephew plc
- Smith and Nephew plc - Overview
- Smith and Nephew plc - Business segments
- Smith and Nephew plc - Key news
- Smith and Nephew plc - Key offerings
- Smith and Nephew plc - Segment focus
- SWOT
- 15.17 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Business segments
- Stryker Corp. - Key news
- Stryker Corp. - Key offerings
- Stryker Corp. - Segment focus
- SWOT
- 15.18 Vericel Corp.
- Vericel Corp. - Overview
- Vericel Corp. - Product / Service
- Vericel Corp. - Key offerings
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
